Ultrastructural study of benign, low-malignant potential (LMP), and malignant ovarian tumors

Medical Electron Microscopy

Volumn 37, Issue 1, 2004, Pages 37-44

  Ishioka, Shin Ichi ^a   Sagae, Satoru ^a   Ito, Eiki ^a   Kado, Ryuichi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Electron microscopy; Histological grading; Low malignant potential; Ovarian cancer

Indexed keywords

ADENOMA; BENIGN TUMOR; CANCER GRADING; CANCER GROWTH; COMPARATIVE STUDY; ENDOMETRIUM TUMOR; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MUELLERIAN DUCT; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; REVIEW; ULTRASTRUCTURE;

ANIMALS; CYSTADENOMA, MUCINOUS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MICROSCOPY, ELECTRON; MITOCHONDRIA; OVARIAN NEOPLASMS;

EID: 1942488926     PISSN: 09184287     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00795-003-0189-0     Document Type: Review

References (26)

1. Tamakoshi K, Kondo T, Yatsuya H, Hori Y, Kikkawa F, Toyoshima H (2001) Trends in the mortality (1950-1997) and incidence (1975-1993) of malignant ovarian neoplasm among Japanese women: analyses by age, time, and birth cohort. Gynecol Oncol 83:64-71
2. Berek JS, Martinez-Maza O (1994) Molecular and biologic factors in the pathogenesis of ovarian cancer. J Reprod Med 39:241-248
3. Aunoble B, Sanches R, Didier E, Bignon YJ (2000) Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review). Int J Oncol 16:567-576
4. Skirnisdottir I, Sorbe B, Seidal T (2001) P53, bcl-2, and bax: their relationship and effect on prognosis in early stage epithelial ovarian carcinoma. Int J Gynecol Cancer 11:147-158
5. Herod JJ, Eliopoulos AG, Warwick J, Niedobitek G, Young LS, Kerr DJ (1996) The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma. Cancer Res 56:2178-2184
6. Kaku T, Ogawa S, Kawano Y, Ohishi Y, Kobayashi H, Hirakawa T, Nakano H (2003) Histological classification of ovarin cancer. Med Electron Microsc 36:9-17
7. Koonings PP, Campbell K, Mishell DR Jr, Grimes DA (1989) Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol 74:921-926
8. Ishioka S, Sagae S, Sugimura M, Nishioka Y, Kobayashi K, Kudo R (2001) Clinical factors and biomarkers which affect a new universal grading system for ovarian epithelial carcinoma. J Obstet Gynaecol Res 27:313-318
9. Scully RE (1995) Pathology of ovarian cancer precursors. J Cell Biochem Suppl 23:208-218
10. Burks RT, Sherman ME, Kurman RJ (1996) Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 20:1319-1330
11. Seto T (1979) Electron microscopic studies of ovarian tumors. I. Serous cystomas. Sapporo Med J 48:1-15
12. Ferenczy A, Richart RM (1974) Endocervical epithelium. In: Ferenczy A, Richart RM (ed(s)) Female reproductive system. Transmission electron microscopy. Wiley Biochemical Health Publication, New York, pp 71-77
13. Ferenczy A, Richart RM (1974) Serous cystadenocarcinoma. In: Ferenczy A, Richart RM (ed(s)) Female reproductive system. Transmission electron microscopy. Wiley Biochemical Health Publication, New York, pp 288-294
14. Nakao K, Meyer C, Noda Y (1971) Progesteron-specific protein crystals in the endometrium, an electron microscopic study. Am J Obstet Gynecol 111:1034-1038
15. Kawase N, Takashina T, Tsukamoto K, Hashimoto M (1979) An ultrastructural study on low potential malignancy of serous cystomas of the ovary. J Clin Electron Microsc 30:333-344
16. Omura GA, Brady MF, Homesley HD, Yordan E, Major FJ, Buchsbaum HJ, Park RC. (1991) Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. J Clin Oncol 9:1138-1150
17. Vercellini P, Scarfone G, Bolis G, Stellato G, Carinelli S, Crosignani PG (2000) Site of origin of epithelial ovarian cancer: the endometriosis connection. BJOG 107:1155-1157
18. Stern RC, Dash R, Bentley RC, Snyder M, Haney AF, Robboy SJ (2001) Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. Int J Gynecol Pathol 20:133-139
19. Bell KA, Kurman RJ (2000) A clinicopathologic ananlysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary. Am J Surg Pathol 24:1465-1479
20. Seto T (1979) Electron microscopic studies of ovarian tumors. Sapporo Med J 48:16-29
21. Towers RP (1956) A note on the origin of the pseudomucinous cystadenoma of the ovary. Br Cwlth 63:253-254
22. Mayer GA (1926) Cystadenoma of the ovary. J Obstet Gynecol 11:383-391
23. Scully RE (1995) Early de novo ovarian cancer and cancer developing in benign ovarian regions. Int J Gynecol Obstet 49:9-15
24. Mandai M, Konishi I Kuroda H, Komatsu T, Yamamoto S, Nanbu K, Matsushita K, Fukumoto M, Yamabe H, Mori T (1998). Heterogeneous distribution of K-ras-mutated epithelia in mucinous ovarian tumors with special references to histopathology. Hum Pathol 29:34-40
25. Garrett AP, Lee KR, Colitti CR, Muto MG, Berkowitz RS, Mok SC (2001). K-ras mutation may be an early event in mucinous ovarian tumorigenesis. Int J Gynecol Pathol 20:244-251
26. Dubeau L (1999) The cell of origin of epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? Gynecol Oncol 72:437-442